Suparna Wedam

2.1k citations
30 papers · 1.4k indexed · h-index 13
Topics
Cancer Treatment and Pharmacology (14 papers)Breast Cancer Treatment Studies (14 papers)Advanced Breast Cancer Therapies (10 papers)

In The Last Decade

Suparna Wedam

27 papers receiving 1.4k citations

Peers

Suparna Wedam
Comparison fields: 5 of 77
  • Oncology 907
  • Cancer Research 478
  • Pulmonary and Respiratory Medicine 468
  • Molecular Biology 364
  • Radiology, Nuclear Medicine and Imaging 261
Replace Zhimin Shao with:
Zhimin Shao China
Linnea Chap United States
Séverine Guiu France
Angelica Fasolo Italy
Rastislav Bahleda France
A. Ramaioli France
J. Thaddeus Beck United States
Anas Gazzah France
Federico Piacentini Italy
Anastasia G Eleftheraki Greece
Suparna Wedam relative to Zhimin Shao China Zhimin Shao's profile →
Citations per field
00.5×1.5×
Zhimin Shao · 1×
Citations per year

Countries citing papers authored by Suparna Wedam

Since Specialization
Citations

This map shows the geographic impact of Suparna Wedam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suparna Wedam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suparna Wedam more than expected).

Fields of papers citing papers by Suparna Wedam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suparna Wedam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suparna Wedam. The network helps show where Suparna Wedam may publish in the future.

Co-authorship network of co-authors of Suparna Wedam

This figure shows the co-authorship network connecting the top 25 collaborators of Suparna Wedam. A scholar is included among the top collaborators of Suparna Wedam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suparna Wedam. Suparna Wedam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 21
5 8
6 2
7 65
8 0
9 194
10 102
11 13
12 114
13 3
14 1
15 58
16 32
17 4
18 172
19 4
20 1

About Suparna Wedam

Suparna Wedam is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (14 papers) and Advanced Breast Cancer Therapies (10 papers). The work is most often cited by research in Oncology (907 citations), Cancer Research (478 citations) and Pulmonary and Respiratory Medicine (468 citations). Suparna Wedam has collaborated with scholars based in United States, Spain and Switzerland. Frequent co-authors include Laleh Amiri‐Kordestani, Richard Pazdur, Sandra M. Swain, Seth M. Steinberg, Erik Bloomquist, Rajeshwari Sridhara, Jennifer A. Low, Arlene Berman, Sherry X. Yang and Julia A. Beaver. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026